The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons

Molecular and Cellular Neuroscience

Volumn 37, Issue 2, 2008, Pages 335-345

  Errico, Francesco ^a   Santini, Emanuela ^b   Migliarini, Sara ^c   Borgkvist, Anders ^b   Centonze, Diego ^d   Nasti, Valentina ^a   Carta, Manolo ^e   De Chiara, Valentina ^d   Prosperetti, Chiara ^d   Spano, Daniela ^a   Herve, Denis ^f,g   Pasqualetti, Massimo ^c   Di Lauro, Roberto ^h   Fisone, Gilberto ^b   Usiello, Alessandro ^a,i  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e LUND UNIVERSITY   (Sweden)

^f INSTITUT DU FER À MOULIN   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h Grande Ospedale Metropolitano   (Italy)

ⁱ UNIVERSITY OF MOLISE   (Italy)

Author keywords

Dopamine; G protien coupled receptor; Knockout mice; Medium spiny neurons; Signal transduction; Striatum

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BICUCULLINE; CYCLIC AMP; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GENE PRODUCT; GOLF PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; QUINPIROLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE; GENE MUTATION; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RHES GENE;

ANIMALS; CORPUS STRIATUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITIC SPINES; DOPAMINE; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEINS; HYPERKINESIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NEURONS; ORGAN CULTURE TECHNIQUES; PHENOTYPE; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

MUS;

EID: 38649098428     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.10.007     Document Type: Article

References (44)

1. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., and Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377 (1995) 424-428
2. Bernal J., and Nunez J. Thyroid hormones and brain development. European journal of endocrinology/European Federation of Endocrine Societies vol. 133 (1995) 390-398
3. Besson M.J., Graybiel A.M., and Quinn B. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39 (1990) 33-58
4. Borgkvist A., Puelles E., Carta M., Acampora D., Ang S.L., Wurst W., Goiny M., Fisone G., Simeone A., and Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Mol. Cell. Neurosci. 31 (2006) 293-302
5. Calabresi P., Fedele E., Pisani A., Fontana G., Mercuri N.B., Bernardi G., and Raiteri M. Transmitter release associated with long-term synaptic depression in rat corticostriatal slices. Eur. J. Neurosci. 7 (1995) 1889-1894
6. Calabresi P., Picconi B., Tozzi A., and Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30 (2007) 211-219
7. Centonze D., Grande C., Saulle E., Martin A.B., Gubellini P., Pavon N., Pisani A., Bernardi G., Moratalla R., and Calabresi P. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J. Neurosci. 23 (2003) 8506-8512
8. Centonze D., Usiello A., Costa C., Picconi B., Erbs E., Bernardi G., Borrelli E., and Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J. Neurosci. 24 (2004) 8214-8222
9. Charpier S., and Deniau J.M. In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7036-7040
10. Choi S., and Lovinger D.M. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2665-2670
11. Corvol J.C., Studler J.M., Schonn J.S., Girault J.A., and Herve D. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J. Neurochem. 76 (2001) 1585-1588
12. Corvol J.C., Valjent E., Pascoli V., Robin A., Stipanovich A., Luedtke R.R., Belluscio L., Girault J.A., and Herve D. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 32 (2007) 1109-1121
13. Falk J.D., Vargiu P., Foye P.E., Usui H., Perez J., Danielson P.E., Lerner D.L., Bernal J., and Sutcliffe J.G. Rhes: A striatal-specific Ras homolog related to Dexras1. J. Neurosci. Res. 57 (1999) 782-788
14. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., and Reppert S.M. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res. 14 (1992) 186-195
15. Gainetdinov R.R., Bohn L.M., Sotnikova T.D., Cyr M., Laakso A., Macrae A.D., Torres G.E., Kim K.M., Lefkowitz R.J., Caron M.G., and Premont R.T. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38 (2003) 291-303
16. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15 (1992) 285-320
17. Geurts M., Hermans E., and Maloteaux J.M. Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding. Life Sci. 65 (1999) 1633-1645
18. Hakansson K., Galdi S., Hendrick J., Snyder G., Greengard P., and Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J. Neurochem. 96 (2006) 482-488
19. Harrison L.M., and LaHoste G.J. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience 137 (2006) 483-492
20. Herve D., Levi-Strauss M., Marey-Semper I., Verney C., Tassin J.P., Glowinski J., and Girault J.A. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J. Neurosci. 13 (1993) 2237-2248
21. Herve D., Le Moine C., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., Jaber M., Studler J.M., and Girault J.A. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J. Neurosci. 21 (2001) 4390-4399
22. Jackson D.M., and Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol. Ther. 64 (1994) 291-370
23. Kemppainen R.J., and Behrend E.N. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J. Biol. Chem. 273 (1998) 3129-3131
24. Kerr J.N., and Wickens J.R. Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J. Neurophysiol. 85 (2001) 117-124
25. Kull B., Svenningsson P., and Fredholm B.B. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol. Pharmacol. 58 (2000) 771-777
26. Le Moine C., and Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355 (1995) 418-426
27. Lindvall O., and Bjorklund A. Anatomy of the dopaminergic neuron systems in the rat brain. Adv. Biochem. Psychopharmacol. 19 (1978) 1-23
28. Marcotte E.R., Sullivan R.M., and Mishra R.K. Striatal G-proteins: effects of unilateral 6-hydroxydopamine lesions. Neurosci. Lett. 169 (1994) 195-198
29. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
30. Paylor R., and Crawley J.N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132 (1997) 169-180
31. Penit-Soria J., Durand C., Besson M.J., and Herve D. Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons. NeuroReport 8 (1997) 829-833
32. Ralph-Williams R.J., Lehmann-Masten V., Otero-Corchon V., Low M.J., and Geyer M.A. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J. Neurosci. 22 (2002) 9604-9611
33. Ralph-Williams R.J., Lehmann-Masten V., and Geyer M.A. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28 (2003) 108-118
34. Reynolds J.N., and Wickens J.R. Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo. Neuroscience 99 (2000) 199-203
35. Rinken A., Finnman U.B., and Fuxe K. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5′(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes. Biochem. Pharmacol. 57 (1999) 155-162
36. Roche K.W., O'Brien R.J., Mammen A.L., Bernhardt J., and Huganir R.L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16 (1996) 1179-1188
37. Schiffmann S.N., Jacobs O., and Vanderhaegen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57 (1991) 1062-1067
38. Spano D., Branchi I., Rosica A., Pirro M.T., Riccio A., Mithbaokar P., Affuso A., Arra C., Campolongo P., Terracciano D., Macchia V., Bernal J., Alleva E., and Di Lauro R. Rhes is involved in striatal function. Mol. Cell. Biol. 24 (2004) 5788-5796
39. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
40. Usiello A., Baik J.H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P.V., and Borrelli E. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408 (2000) 199-203
41. Vargiu P., Morte B., Manzano J., Perez J., de Abajo R., Gregor Sutcliffe J., and Bernal J. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Brain Res. 94 (2001) 1-8
42. Vargiu P., De Abajo R., Garcia-Ranea J.A., Valencia A., Santisteban P., Crespo P., and Bernal J. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23 (2004) 559-568
43. Welter M., Vallone D., Samad T.A., Meziane H., Usiello A., and Borrelli E. Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6840-6845
44. Zhuang X., Belluscio L., and Hen R. G(olf)alpha mediates dopamine D1 receptor signaling. J. Neurosci. 20 (2000) RC91